National Bank of Canada
HUMA icon

National Bank of Canada’s Humacyte HUMA Stock Holding History

National Bank of Canada’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09K Buy
+1,800
New +$1.87K ﹤0.01% 2666
2025
Q3 		– Sell
-653,200
Closed -$1.37M – 3015
2025
Q2 		$1.37M Sell
653,200
-138,600
-18% -$266K ﹤0.01% 1220
2025
Q1 		$1.35M Buy
+791,800
New +$2.97M ﹤0.01% 1137
2024
Q4 		– Sell
-2
Closed -$11 – 3048
2024
Q3 		$11 Buy
+2
New +$13 ﹤0.01% 2691

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

National Bank of Canada's HUMA Position: Q1 2026 in Review

National Bank of Canada opened a new position in Humacyte (HUMA) in Q1 2026: 1,800 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #2666 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in HUMA as recently as Q2 2025.

National Bank of Canada first reported a position in HUMA in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.37M in Q2 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • National Bank of Canada held 1,800 shares of Humacyte worth $1.09K as of Q1 2026.
  • Humacyte was a new National Bank of Canada position in Q1 2026.
  • Humacyte made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2666 holding.
  • National Bank of Canada first reported a position in Humacyte in Q3 2024 and has held it in 4 quarters since.
  • National Bank of Canada's Humacyte position peaked at $1.37M in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.